#151070

Anti-p13 [AA10.2]

Cat. #151070

Anti-p13 [AA10.2]

Cat. #: 151070

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: p13 (SUC1)

Class: Monoclonal

Application: IHC ; IP ; WB

Reactivity: Schizosaccharomyces pombe

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Julian Gannon

Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-p13 [AA10.2]
  • Research fields: Cell biology;Genetics
  • Clone: AA10.2
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Schizosaccharomyces pombe
  • Host: Mouse
  • Application: IHC ; IP ; WB
  • Description: p13 SUC1 is a CDK subunit from S. pombe that interacts with CDK1. p13 SUC1 is used exclusively to capture CDK1 complexes from various cell lines and egg extracts.
  • Immunogen: p13
  • Isotype: IgG1 kappa
  • Myeloma used: Sp2/0-Ag14
  • Recommended controls: Raji cells or breast carcinomas.

Target Details

  • Target: p13 (SUC1)
  • Tissue cell line specificity: Raji cells or breast carcinomas.
  • Target background: p13 SUC1 is a CDK subunit from S. pombe that interacts with CDK1. p13 SUC1 is used exclusively to capture CDK1 complexes from various cell lines and egg extracts.

Applications

  • Application: IHC ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Yang et al. 2005. J Am Soc Nephrol. 16(10):2890-6. PMID: 16107581.
  • Redistribution of myosin VI from top to base of proximal tubule microvilli during acute hypertension.
  • Gee et al. 1999. J Pathol. 189(4):514-20. PMID: 10629551.
  • Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer.
  • Batsch et al. 1998. Mol Cell Biol. 18(7):3647-58. PMID: 9632747.
  • RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2.